BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8573548)

  • 1. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.
    Little WC; Cheng CP; Elvelin L; Nordlander M
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):657-63. PubMed ID: 8573548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular versus myocardial effects of calcium antagonists.
    Little WC; Cheng CP
    Drugs; 1994; 47 Suppl 4():41-5; discussion 45-6. PubMed ID: 7523061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension.
    Walton T; Symes LR
    Clin Pharm; 1993 Apr; 12(4):261-75. PubMed ID: 8458178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine.
    Gradman AH
    Can J Cardiol; 1995 Apr; 11 Suppl B():14B-21B. PubMed ID: 7728649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of calcium channel antagonists for cardiovascular disease.
    Yedinak KC
    Am Pharm; 1993 Aug; NS33(8):49-64; quiz 64-6. PubMed ID: 8213473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of calcium channel blockers in hypertensive patients with concomitant left ventricular dysfunction.
    Parmley WW
    Clin Cardiol; 1992 Apr; 15(4):235-42. PubMed ID: 1563126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists.
    Vetrovec GW
    Am J Cardiol; 1994 Jan; 73(3):34A-38A. PubMed ID: 8310974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
    Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF
    Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function.
    Gradman AH
    Am Heart J; 1992 Jan; 123(1):273-8. PubMed ID: 1729848
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of calcium channel blocking agents on cardiovascular function.
    Low RI; Takeda P; Mason DT; DeMaria AN
    Am J Cardiol; 1982 Feb; 49(3):547-53. PubMed ID: 7058766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
    White CM
    Conn Med; 1997 Oct; 61(10):659-61. PubMed ID: 9375452
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
    de Vries RJ; van Veldhuisen DJ; Dunselman PH
    Am Heart J; 2000 Feb; 139(2 Pt 1):185-94. PubMed ID: 10650289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the cardiodepressive effects of nifedipine, isradipine, nisoldipine and felodipine in patients with coronary heart disease].
    Mauser M; Voelker W; Ickrath O; Karsch KR
    Z Kardiol; 1993 Jan; 82(1):17-27. PubMed ID: 8470415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies with felodipine in congestive heart failure.
    Timmis AD; Jewitt DE
    Drugs; 1985; 29 Suppl 2():66-75. PubMed ID: 3987553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension.
    Cheung BM; Lau CP; Wu BZ
    Clin Ther; 1998; 20(6):1159-69. PubMed ID: 9916609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.